Nuveen Asset Management, LLC Avidity Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,073,859 shares of RNA stock, worth $28.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,073,859

Previous 490,594 118.89%

Holding current value

$28.8 Million

Previous $4.44 Million 517.35%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$9.16 - $25.52 $5.34 Million - $14.9 Million	583,265 Added 118.89%	1,073,859 $27.4 Million
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $1.36 Million - $2.62 Million	279,718 Added 132.65%	490,594 $4.44 Million
Q3 2023 Nov 14, 2023	SELL	$6.3 - $11.35 $10,483 - $18,886	-1,664 Reduced 0.78%	210,876 $1.35 Million
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $64,813 - $105,826	6,103 Added 2.96%	212,540 $2.36 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $439,270 - $734,026	28,617 Added 16.09%	206,437 $3.17 Million

Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $354,665 - $798,878	35,255 Added 24.73%	177,820 $3.95 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $23.43 $632,267 - $958,216	-40,897 Reduced 22.29%	142,565 $2.33 Million
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $788,257 - $1.45 Million	70,506 Added 62.42%	183,462 $2.67 Million
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $17,579 - $29,439	-1,238 Reduced 1.08%	112,956 $1.99 Million
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $160,609 - $225,640	-7,873 Reduced 6.45%	114,194 $2.69 Million
Q3 2021 Nov 12, 2021	BUY	$18.16 - $25.21 $72,767 - $101,016	4,007 Added 3.39%	122,067 $2.93 Million
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $427,794 - $637,985	21,804 Added 22.65%	118,060 $2.92 Million
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $630,789 - $875,577	31,104 Added 47.74%	96,256 $2.1 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $5,218 - $7,410	211 Added 0.32%	65,152 $1.66 Million
Q3 2020 Nov 16, 2020	BUY	$23.35 - $35.94 $1.52 Million - $2.33 Million	64,941 New	64,941 $1.83 Million

Others Institutions Holding RNA

# of Institutions

164

Shares Held

71.6M

Call Options Held

182K

Put Options Held

55K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.4B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Avidity Biosciences, Inc. Transaction History